Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Amino acid sequence disclosed in whole or in part; or...
Reexamination Certificate
2006-01-03
2006-01-03
Scheiner, Laurie (Department: 1648)
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Amino acid sequence disclosed in whole or in part; or...
C424S001570, C424S009100, C424S009200, C424S193100, C424S197110, C424S236100, C436S086000, C436S507000, C514S021800, C530S324000, C530S327000, C530S329000, C530S330000
Reexamination Certificate
active
06982084
ABSTRACT:
The invention provides compositions and methods for treatment of amyloidogenic diseases. Such methods entail administering an agent that induces a beneficial immune response against an amyloid deposit in the patient. The methods are particularly useful for prophylactic and therapeutic treatment of Alzheimer's disease. In such methods, a suitable agent is Aβ peptide or an antibody thereto.
REFERENCES:
patent: 4666829 (1987-05-01), Glenner et al.
patent: 4713366 (1987-12-01), Stevens
patent: 5004697 (1991-04-01), Pardridge
patent: 5057540 (1991-10-01), Kensil et al.
patent: 5187153 (1993-02-01), Cordell et al.
patent: 5192753 (1993-03-01), McGeer et al.
patent: 5208036 (1993-05-01), Eppstein et al.
patent: 5220013 (1993-06-01), Ponte et al.
patent: 5231000 (1993-07-01), Majocha et al.
patent: 5231170 (1993-07-01), Averback
patent: 5270165 (1993-12-01), Van Nostrand et al.
patent: 5387742 (1995-02-01), Cordell
patent: 5434170 (1995-07-01), Andrulis, Jr.
patent: 5441870 (1995-08-01), Seubert et al.
patent: 5464823 (1995-11-01), Lehrer et al.
patent: 5571499 (1996-11-01), Hafler et al.
patent: 5571500 (1996-11-01), Hafler et al.
patent: 5958883 (1999-09-01), Snow
patent: 5985242 (1999-11-01), Findeis et al.
patent: 5989566 (1999-11-01), Cobb et al.
patent: 6057367 (2000-05-01), Stamler et al.
patent: 6114133 (2000-09-01), Seubert et al.
patent: 6150091 (2000-11-01), Pandolfo et al.
patent: 6262335 (2001-07-01), Hsiao et al.
patent: 6284221 (2001-09-01), Schenk et al.
patent: 6284533 (2001-09-01), Thomas
patent: 6294171 (2001-09-01), McMichael
patent: 6303567 (2001-10-01), Findeis et al.
patent: 6399314 (2002-06-01), Krishnamurthy
patent: 6417178 (2002-07-01), Klunk et al.
patent: 6562341 (2003-05-01), Prusiner et al.
patent: 2001/0018053 (2001-08-01), McMichael
patent: 2001/0021769 (2001-09-01), Prusiner
patent: 2002/0009445 (2002-01-01), Du et al.
patent: 2002/0077288 (2002-06-01), Frangione
patent: 2002/0086847 (2002-07-01), Chain
patent: 2002/0094335 (2002-07-01), Chalifour et al.
patent: 2002/0102261 (2002-08-01), Raso
patent: 2002/0132268 (2002-09-01), Chang et al.
patent: 2002/0133001 (2002-09-01), Gefter et al.
patent: 2002/0136718 (2002-09-01), Raso
patent: 2002/0160394 (2002-10-01), Wu
patent: 2002/0162129 (2002-10-01), Lannfelt
patent: 2002/0168377 (2002-11-01), Schaetzl
patent: 2002/0187157 (2002-12-01), Jensen et al.
patent: 2002/0197258 (2002-12-01), Ghanbari et al.
patent: 2003/0068325 (2003-04-01), Wang
patent: 2003/0073655 (2003-04-01), Chain
patent: 2003/0165496 (2003-09-01), Basi et al.
patent: 2003/0166558 (2003-09-01), Frangione et al.
patent: 451 700 (1991-10-01), None
patent: 276 723 (1993-12-01), None
patent: 613 007 (1994-08-01), None
patent: 666 080 (1995-08-01), None
patent: 359 783 (1995-11-01), None
patent: 683 234 (1995-11-01), None
patent: 440 619 (1996-01-01), None
patent: 526 511 (1997-05-01), None
patent: 782 859 (1997-07-01), None
patent: 783 104 (1997-07-01), None
patent: 594 607 (1997-08-01), None
patent: 845 270 (1998-06-01), None
patent: 863 211 (1998-09-01), None
patent: 868 918 (1998-10-01), None
patent: 652 962 (1998-12-01), None
patent: 911 036 (1999-04-01), None
patent: 561 087 (1999-08-01), None
patent: 639 081 (1999-11-01), None
patent: 506 785 (2000-03-01), None
patent: 1 172 378 (2002-01-01), None
patent: 2 220 211 (1990-01-01), None
patent: 2 335 192 (1999-09-01), None
patent: WO 88/10120 (1988-12-01), None
patent: WO 89/01343 (1989-02-01), None
patent: WO 89/03687 (1989-05-01), None
patent: WO 89/06242 (1989-07-01), None
patent: WO 89/06689 (1989-07-01), None
patent: WO 90/12870 (1990-11-01), None
patent: WO 90/12871 (1990-11-01), None
patent: WO 91/08760 (1991-06-01), None
patent: WO 91/12816 (1991-09-01), None
patent: WO 91/16819 (1991-11-01), None
patent: WO 91/19810 (1991-12-01), None
patent: WO 92/06187 (1992-04-01), None
patent: WO 92/06708 (1992-04-01), None
patent: WO 92/13069 (1992-08-01), None
patent: WO 93/02189 (1993-02-01), None
patent: WO 93/04194 (1993-03-01), None
patent: WO 93/14200 (1993-07-01), None
patent: WO 93/15760 (1993-08-01), None
patent: WO 93/16724 (1993-09-01), None
patent: WO 93/21950 (1993-11-01), None
patent: WO 94/01772 (1994-01-01), None
patent: WO 94/03615 (1994-02-01), None
patent: WO 94/28412 (1994-12-01), None
patent: WO 95/04151 (1995-02-01), None
patent: WO 95/05853 (1995-03-01), None
patent: WO 95/11008 (1995-04-01), None
patent: WO 95/11311 (1995-04-01), None
patent: WO 95/11994 (1995-05-01), None
patent: WO 95/12815 (1995-05-01), None
patent: WO 95/31996 (1995-11-01), None
patent: WO 96/18900 (1996-06-01), None
patent: WO 96/25435 (1996-08-01), None
patent: WO 96/28471 (1996-09-01), None
patent: WO 96/39176 (1996-12-01), None
patent: WO 97/10505 (1997-03-01), None
patent: WO 97/17613 (1997-05-01), None
patent: WO 97/21728 (1997-06-01), None
patent: WO 98/07850 (1998-02-01), None
patent: WO 98/44955 (1998-10-01), None
patent: WO 99/00150 (1999-01-01), None
patent: WO 99/06066 (1999-02-01), None
patent: WO 99/27911 (1999-06-01), None
patent: WO 99/27944 (1999-06-01), None
patent: WO 99/27949 (1999-06-01), None
patent: WO 99/06545 (1999-11-01), None
patent: WO 99/58564 (1999-11-01), None
patent: WO 99/60021 (1999-11-01), None
patent: WO 99/60024 (1999-11-01), None
patent: WO 01/62284 (2000-03-01), None
patent: WO 00/43039 (2000-07-01), None
patent: WO 00/43049 (2000-07-01), None
patent: WO 00/72870 (2000-12-01), None
patent: WO 00/72876 (2000-12-01), None
patent: WO 00/72876 (2000-12-01), None
patent: WO 00/72880 (2000-12-01), None
patent: WO 00/72880 (2000-12-01), None
patent: WO 00/77178 (2000-12-01), None
patent: WO 02/03911 (2001-04-01), None
patent: WO 01/39796 (2001-06-01), None
patent: WO 01/42306 (2001-06-01), None
patent: WO 01/62801 (2001-08-01), None
patent: WO 01/77167 (2001-10-01), None
patent: WO 01/90182 (2001-11-01), None
patent: WO 02/34777 (2002-05-01), None
patent: WO 02/34878 (2002-05-01), None
patent: WO 03/020212 (2003-03-01), None
Aguzzi et al., “Prion research: the next frontiers,”Nature,389:795-798 (1997).
Akiyama et al., “Inflammation and Alzheimer's disease,”Neurobiology of Aging,21:383-421 (2000).
Akiyama et al., “Occurrence of the Diffuse Amyloid β-Protein (Aβ) Deposits With Numerous Aβ-Containing Glial Cells in the Cerebral Cortex of Patients With Alzheimer's Disease,”Glia,25:324-331 (1999).
Andersen et al., “Do nonsteroidal anti-inflammatory drugs decrease the risk for Alzheimer's disease?”,Neurology,45:1441-1445 (1995).
Associated Press, “Immune cells may promote Alzheimer's a study finds,”The Boston Globe(Apr. 13, 1995).
Bard et al., “Peripherally administered antibodies against amyloid β-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease,”Nature Medicine,6(8):916-919 (2000).
Barrow, et al., “Solution Conformations and aggregational Properties of Synthetic Amyloid Beta-Peptides of Alzheimer's Disease. Analysis of Circular Dichroism Spectra”,J. Mol. Biol.,225(4): 1075-1093 (1992).
Bauer et al., “Interleukin-6 and α-2-macroglobulin indicate an acute-phase state in Alzheimer's disease cortices,”FEBS Letters,285(1):111-114 (1991).
Beasley, “Alzheimer's traced to proteins caused by aging,” Reuters, Apr. 20, 2001 7:56 PM ET.
Benjamini and Leskowitz, fromImmunology A Short Course,Second Edition, Chapter 4, Antibody Structure, pp. 49-65, 1991, published by Wiley-Liss, New York, New York.
Bercovici et al., “Chronic Intravenous Injections of Antigen Induce and Maintain Tolerance in T Cell Receptor-Transgenic Mice,”Eur. J. Immunol.29:345-354 (1999).
Bickel et al., “Site Protected, Cationized Monoclonal Antibody Against Beta Amyloid as a Potential Diagnostic Imaging Technique for Alzheimer's Diseases,”Soc. for Neuroscience Abstracts18:764 (1992).
Blass, “Immunologic Treatment of Alzheimer's Disease,”New England J. Medicine,341 (22):1694 (1999).
Bodmer et al., “Transforming Growth Factor-Beta Bound to Soluble Derivativ
NeuraLab Limited
Scheiner Laurie
Townsend and Townsend / and Crew LLP
LandOfFree
Prevention and treatment of amyloidogenic disease does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Prevention and treatment of amyloidogenic disease, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Prevention and treatment of amyloidogenic disease will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3579624